Open Access

Real-world evidence in practice: stroke prevention with non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation

Event: ESC Congress 2022
Topic: Atrial Fibrillation (AF)
Session type: Satellite Symposium
Sponsored by BMS/Pfizer Alliance
Date: 26 August 2022
Time: 15:30 - 16:15

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

4 presentations in this session

What can robust real-world evidence bring to the table?

Speaker: Professor G. Lip (Liverpool, GB)
Thumbnail

Real-world evidence complements randomised controlled trial data to inform daily clinical practice.

Speaker: Doctor S. Deitelzweig (New Orleans, US)
Thumbnail

Stroke prevention in sub-populations of patients with non-valvular atrial fibrillation.

Speaker: Professor G. Lip (Liverpool, GB)
Thumbnail

Audience participation.

Speaker: Professor G. Lip (Liverpool, GB)
Thumbnail

4 speakers from this session

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
70 presentations
5 followers

Doctor Steven Deitelzweig

Ochsner Clinic Foundation, New Orleans (United States of America)
7 presentations
0 follower

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
70 presentations
5 followers

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
70 presentations
5 followers

This platform is supported by

logo Novo Nordisk